News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study Presenter: Eric Boersma, James E. Muller November 01, 2016
Presentation TCT 2016 TCT 599: Not All Plaque Ruptures Are Born Equal: An Optical Coherence Tomography Study Presenter: Eric Boersma, James E. Muller November 01, 2016
Presentation TCT 2016 TCT 598: Plaque Rupture in Coronary Atherosclerosis is Associated with Increased Plaque Structural Stress Presenter: Eric Boersma, James E. Muller November 01, 2016
Presentation TCT 2016 TCT 597: Why Does Thin-Cap Fibroatheroma Cluster in the Proximal egment in Left Anterior Coronary Artery, But Are Evenly Distributed Throughout the Entire Right Coronary Artery? Results from Computational Fluid Dynamics Simulation by CT-FFR Presenter: Eric Boersma, James E. Muller November 01, 2016
Presentation TCT 2016 My Top Predictions for the Next Decade of Vulnerable Plaque Research: Insights From a Soothsayer Presenter: Gregg W. Stone, Ron Waksman, John A. Ambrose November 01, 2016
Presentation TCT 2016 Put Away Your Catheters! Nanomedicines to Treat Vulnerable Plaque Presenter: Gregg W. Stone, Ron Waksman, Jonathan Leor November 01, 2016
Presentation TCT 2016 Are PCSK9 Inhibitors and Anti-inflammatory Therapies for Vulnerable Plaque Right Around the Corner? Presenter: Gregg W. Stone, Ron Waksman, Sanjit S. Jolly November 01, 2016
Presentation TCT 2016 To Treat or Not to Treat (Focally): From Stable to PROSPECT-ABSORB and PREVENT Presenter: Gregg W. Stone, Ron Waksman, Seung-Jung Park November 01, 2016
Presentation TCT 2016 Bioresorbable Scaffolds for Vulnerable Plaque Treatment: Rationale for Focal Therapy, Early Clinical Experiences, and Will it Succeed?! Presenter: Gregg W. Stone, Ron Waksman, Vasim Farooq November 01, 2016
Presentation TCT 2016 Detecting and Differentiating Plaque Erosion vs Rupture and Does It Matter? Presenter: John A. Ambrose, Peter H. Stone, Giulio Guagliumi November 01, 2016
Presentation TCT 2016 Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal Presenter: John A. Ambrose, Peter H. Stone, Guillermo Tearney November 01, 2016
Presentation TCT 2016 NIRS Detection of Vulnerable Plaque: The Story Is Intensifying Presenter: John A. Ambrose, Peter H. Stone, David Erlinge November 01, 2016
Presentation TCT 2016 What Makes a Plaque Vulnerable: Morphology, Chemistry, Biologic Activity, or Ischemia? Presenter: John A. Ambrose, Peter H. Stone November 01, 2016
Presentation TCT 2016 The Greatest Misconceptions Doctors STILL Believe About Vulnerable Plaques and Patients: Reflections From a Pioneer Presenter: John A. Ambrose, Peter H. Stone, James E. Muller November 01, 2016
Presentation TCT 2016 CKD, Atherosclerosis, and Vascular Calcification: Essentials for the Interventionalist Presenter: Somjot S. Brar, Richard Solomon, Anand Prasad November 01, 2016
Presentation TCT 2016 TCT 359: Ulnar Artery Transient Compression Facilitating Radial Artery patent hemostasis (ULTRA). A Novel Technique to Reduce Radial Artery Occlusion Presenter: Ivo Bernat, Thomas M. Tu November 01, 2016
Presentation TCT 2016 TCT 358: Bleeding and Vascular Complication Rates Before and After Implementation of a Radial Coronary Catheterization Programme an Observational Study in 12 745 Patients Presenter: Ivo Bernat, Thomas M. Tu November 01, 2016
Presentation TCT 2016 TCT 547: Radial Artery Changes After Transradial PCI A Serial Optical Coherence Tomography Volumetric Study Presenter: Ivo Bernat, Thomas M. Tu November 01, 2016
News Industry News Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque November 01, 2016